Acumen Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.36

+0.17 (+7.76%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +841.5% upside

Low Target $18.81

Average Target $22.22

High Target $35.10

Current Price $2.36

Current
$2.36

Target
$22.22

$18.81 $22.22 avg $35.10

Scenario Analysis

Bear Case

$18.81

697.0%

Low target

Base Case

$22.22

+841.5%

Avg target

Bull Case

$35.10

+1,387.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$3.60

-34.4% from high

52-Week Low

$0.86

+176.0% from low

Target vs 52W High

$22.22

+517.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%